Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 9/28/12 → 9/28/15 |
Funding
- PPD Development (Prot #GS-US-312-0116 // Prot #GS-US-312-0116)
- Gilead Sciences, Inc (Prot #GS-US-312-0116 // Prot #GS-US-312-0116)
Prot #GS-US-312-0116: A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of GS-1101 (CAL-101) in Combination with Rituximab for Previously Treated Chronic Lymphocytic Leukemia
- Ma, Shuo (PD/PI)
Project: Research project